Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.38 USD | -1.83% | -.--% | +74.10% |
Sales 2024 * | 123M 133M 10.44B | Sales 2025 * | 325M 353M 27.7B | Capitalization | 2.58B 2.8B 220B |
---|---|---|---|---|---|
Net income 2024 * | -430M -466M -36.62B | Net income 2025 * | -116M -126M -9.88B | EV / Sales 2024 * | 21.8 x |
Net Debt 2024 * | 89.28M 96.82M 7.6B | Net cash position 2025 * | 94.69M 103M 8.06B | EV / Sales 2025 * | 7.65 x |
P/E ratio 2024 * |
-6.08
x | P/E ratio 2025 * |
-33
x | Employees | 464 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 17.23% |
Latest transcript on MorphoSys AG
1 day | -1.83% | ||
3 months | +1.57% | ||
6 months | +160.99% | ||
Current year | +74.10% |
Managers | Title | Age | Since |
---|---|---|---|
Jean-Paul Kress
CEO | Chief Executive Officer | 59 | 31/08/19 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 45 | 06/08/23 |
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brosnan
BRD | Director/Board Member | 69 | 16/05/18 |
Director/Board Member | 67 | 16/05/18 | |
Marc Cluzel
CHM | Chairman | 69 | 30/05/12 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.34% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- MOR Stock
- MPSYF Stock